Immunohistochemical expression of 14-3-3 σ protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas

14-3-3 sigma (sigma) has been shown to be overexpressed in pancreatic cancers by a c-DNA microarray technique. However, the expression of 14-3-3 sigma in intraductal papillary-mucinous tumor (IPMT) of the pancreas remains unclear. To evaluate the biological importance of 14-3-3 sigma expression in p...

Full description

Saved in:
Bibliographic Details
Published inAnticancer research Vol. 26; no. 4B; pp. 3105 - 3110
Main Authors OKADA, Toshiyuki, MASUDA, Norihiro, FUKAI, Yasuyuki, SHIMURA, Tatsuo, NISHIDA, Yasuji, HOSOUCHI, Yasuo, KASHIWABARA, Kenji, NAKAJIMA, Takashi, KUWANO, Hiroyuki
Format Journal Article
LanguageEnglish
Published Attiki International Institute of Anticancer Research 01.07.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:14-3-3 sigma (sigma) has been shown to be overexpressed in pancreatic cancers by a c-DNA microarray technique. However, the expression of 14-3-3 sigma in intraductal papillary-mucinous tumor (IPMT) of the pancreas remains unclear. To evaluate the biological importance of 14-3-3 sigma expression in pancreatic carcinogenesis, immunohistochemistry for 14-3-3 sigma, CDX2, MUC1, MUC2, p53, p16 and Ki-67 was carried out on 33 IPMTs and the results were compared with those for 14 invasive ductal carcinomas (IDCs). The frequency of 14-3-3 sigma immunoreactivity was 70% and 100% in IPMT and IDC, respectively. The frequency of MUCI and Ki-67 immunoreactivity was significantly higher in IDC than IPMT. In IPMT, dark columnar cell types prevailed over clear columnar cell types in terms of the frequency of the Ki-67 labeling index. The overexpression of 14-3-3 sigma was confirmed in both IDC and IPMT. Therefore, this overexpression might occur in the early stages of pancreatic carcinogenesis. Moreover, IPMT composed of dark columnar cells might be a potentially more advanced form than that made up of clear columnar cells.
ISSN:0250-7005
1791-7530